Frank Neumann

3.4k total citations
103 papers, 2.3k citations indexed

About

Frank Neumann is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Frank Neumann has authored 103 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 29 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in Frank Neumann's work include Immunotherapy and Immune Responses (21 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Immune Cell Function and Interaction (16 papers). Frank Neumann is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Immune Cell Function and Interaction (16 papers). Frank Neumann collaborates with scholars based in Germany, United States and France. Frank Neumann's co-authors include Michael Pfreundschuh, Ulrich Krawinkel, Rainer Haas, Guido Kobbe, Roland Fenk, Klaus‐Dieter Preuss, Ralf Kronenwett, Boris Kubuschok, Joerg Thomas Bittenbring and Ingmar Bruns and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Frank Neumann

99 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Neumann Germany 29 757 752 665 595 306 103 2.3k
S Tagawa Japan 16 901 1.2× 602 0.8× 489 0.7× 415 0.7× 417 1.4× 47 1.9k
C. Zurcher Netherlands 29 560 0.7× 922 1.2× 514 0.8× 655 1.1× 245 0.8× 91 2.7k
Jean Ripoche France 30 1.1k 1.5× 632 0.8× 749 1.1× 250 0.4× 114 0.4× 80 2.8k
Hiroshi Handa Japan 28 666 0.9× 1.5k 2.0× 1.2k 1.8× 512 0.9× 552 1.8× 222 3.5k
Charles Perkins United States 22 753 1.0× 1.2k 1.6× 576 0.9× 399 0.7× 88 0.3× 35 2.7k
William K. Decker United States 22 1.0k 1.3× 899 1.2× 353 0.5× 975 1.6× 152 0.5× 76 2.6k
Igor Espinoza‐Delgado United States 32 786 1.0× 1.7k 2.3× 515 0.8× 959 1.6× 256 0.8× 78 3.1k
Thomas G. Diacovo United States 33 1.3k 1.7× 1.1k 1.5× 1.0k 1.6× 517 0.9× 77 0.3× 53 3.5k
Hiromi Tagoh United Kingdom 31 1.7k 2.2× 1.4k 1.9× 448 0.7× 1.0k 1.8× 340 1.1× 59 3.9k
Thomas Moritz Germany 27 649 0.9× 1.1k 1.5× 257 0.4× 423 0.7× 234 0.8× 90 2.8k

Countries citing papers authored by Frank Neumann

Since Specialization
Citations

This map shows the geographic impact of Frank Neumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Neumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Neumann more than expected).

Fields of papers citing papers by Frank Neumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Neumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Neumann. The network helps show where Frank Neumann may publish in the future.

Co-authorship network of co-authors of Frank Neumann

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Neumann. A scholar is included among the top collaborators of Frank Neumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Neumann. Frank Neumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Martin, Lisa J., James B. Whitmore, Rhine R. Shen, & Frank Neumann. (2024). T-cell malignancies with anti-CD19 chimeric antigen receptor T-cell therapy. Blood Advances. 8(15). 4144–4148. 1 indexed citations
3.
Neumann, Frank, Konstantinos Christofyllakis, Igor Age Kos, et al.. (2024). Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas. Scientific Reports. 14(1). 9571–9571. 1 indexed citations
4.
Christofyllakis, Konstantinos, Frank Neumann, Moritz Bewarder, et al.. (2023). Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies. Nutrients. 15(16). 3498–3498. 5 indexed citations
5.
Kos, Igor Age, Joerg Thomas Bittenbring, Manfred Ahlgrimm, et al.. (2022). Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2. Expert Review of Vaccines. 21(11). 1683–1689. 1 indexed citations
6.
Bewarder, Moritz, Stephan Stilgenbauer, Konstantinos Christofyllakis, et al.. (2020). Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma. Frontiers in Oncology. 10. 580364–580364. 5 indexed citations
7.
Thurner, Lorenz, Sylvia Hartmann, Frank Neumann, et al.. (2020). Role of Specific B-Cell Receptor Antigens in Lymphomagenesis. Frontiers in Oncology. 10. 604685–604685. 13 indexed citations
8.
Bewarder, Moritz, Gerhard Held, Lorenz Thurner, et al.. (2020). Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential. Cancer Immunology Immunotherapy. 69(8). 1535–1548. 4 indexed citations
9.
Bochen, Florian, Joerg Thomas Bittenbring, Frank Neumann, et al.. (2018). Vitamin D deficiency in head and neck cancer patients – prevalence, prognostic value and impact on immune function. OncoImmunology. 7(9). e1476817–e1476817. 47 indexed citations
10.
Neumann, Frank, et al.. (2018). Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity. Cancer Immunology Immunotherapy. 67(11). 1709–1718. 9 indexed citations
11.
Wadle, Andreas, Axel Mischo, Sabine Strahl, et al.. (2010). NY‐ESO‐1 protein glycosylated by yeast induces enhanced immune responses. Yeast. 27(11). 919–931. 9 indexed citations
12.
Neumann, Frank, Fabian Zohren, & Rainer Haas. (2009). The role of natalizumab in hematopoietic stem cell mobilization. Expert Opinion on Biological Therapy. 9(8). 1099–1106. 20 indexed citations
13.
Neumann, Frank, Roland Fenk, Michael Wulfert, et al.. (2008). Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study. Hematological Oncology. 26(4). 213–218. 1 indexed citations
14.
Bruns, Ingmar, Frank Neumann, Johannes Fischer, et al.. (2007). Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 21(3). 494–504. 113 indexed citations
15.
Neumann, Frank, Simona Martin, Ralf Kronenwett, et al.. (2006). Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin’s lymphoma. Annals of Hematology. 85(8). 530–534. 18 indexed citations
16.
Kronenwett, Ralf, Ulrich Steidl, Frank Neumann, et al.. (2005). Distinct molecular phenotype of malignant CD34+ hematopoietic stem and progenitor cells in chronic myelogenous leukemia. Oncogene. 24(34). 5313–5324. 39 indexed citations
17.
Steidl, Ulrich, Roland Fenk, Ingmar Bruns, et al.. (2004). Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplantation. 35(1). 33–36. 68 indexed citations
18.
Neumann, Frank, Barbara Hildebrandt, Guido Kobbe, et al.. (2003). Quantitative real‐time reverse‐transcription polymerase chain reaction for diagnosis of BCR‐ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation. European Journal Of Haematology. 70(1). 1–10. 29 indexed citations
19.
Türeci, Özlem, Uğur Şahin, C. Zwick, Frank Neumann, & Michael Pfreundschuh. (1999). Exploitation of the Antibody Repertoire of Cancer Patients for the Identification of Human Tumor Antigens. Hybridoma. 18(1). 23–28. 46 indexed citations
20.
Türeci, Özlem, et al.. (1999). Identification of human tumor antigens using the antibody repertoire of cancer patients. 48. 93–101. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Tagawa Breakdown of academic impact, for papers by C. Zurcher Breakdown of academic impact, for papers by Jean Ripoche Breakdown of academic impact, for papers by Hiroshi Handa Breakdown of academic impact, for papers by Charles Perkins Breakdown of academic impact, for papers by William K. Decker Breakdown of academic impact, for papers by Igor Espinoza‐Delgado Breakdown of academic impact, for papers by Thomas G. Diacovo Breakdown of academic impact, for papers by Hiromi Tagoh Breakdown of academic impact, for papers by Thomas Moritz
Rankless by CCL
2026